Variant report
Variant | nsv524409 |
---|---|
Chromosome Location | chr20:15807441-15808444 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
Variant overlapped rSNPs/rCNVs (count:36 , 50 per page) page:
1
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6135562 | chr20:15807441-15807442 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs140130523 | chr20:15807446-15807447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566920722 | chr20:15807463-15807464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184637774 | chr20:15807490-15807491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565295585 | chr20:15807621-15807622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577281560 | chr20:15807665-15807666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201067870 | chr20:15807674-15807675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145554752 | chr20:15807744-15807745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73898518 | chr20:15807794-15807795 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs73614464 | chr20:15807804-15807805 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs560712535 | chr20:15807813-15807814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141003132 | chr20:15807827-15807828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149842097 | chr20:15807843-15807844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570935098 | chr20:15807892-15807893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73246742 | chr20:15807905-15807906 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs145719779 | chr20:15807908-15807909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569097707 | chr20:15807915-15807916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536544969 | chr20:15807971-15807972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554502293 | chr20:15808003-15808004 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558207250 | chr20:15808050-15808051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73614465 | chr20:15808094-15808095 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs554815440 | chr20:15808131-15808132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76229991 | chr20:15808152-15808153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577318324 | chr20:15808187-15808188 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544318865 | chr20:15808206-15808207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189570677 | chr20:15808210-15808211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575057150 | chr20:15808248-15808249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192259861 | chr20:15808280-15808281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35416828 | chr20:15808282-15808283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560332463 | chr20:15808319-15808320 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527853612 | chr20:15808334-15808335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185852699 | chr20:15808343-15808344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189474421 | chr20:15808369-15808370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547099361 | chr20:15808418-15808419 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532225568 | chr20:15808441-15808442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs6034296 | chr20:15808444-15808445 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
Multiple sclerosis | 20663923 | CNVD |
Schizophrenia | 20663923 | CNVD |
brain infarct | 20663923 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:15806000-15812000 | Weak transcription | Gastric | stomach |
2 | chr20:15808000-15808200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr20:15808000-15808600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr20:15808000-15808800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr20:15808000-15808800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr20:15808200-15808600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr20:15808200-15808600 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr20:15808200-15808600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |